Researchers investigate 59 tumor cell lines

August 8, 2013
The protein signatures show how sensitively the tumor cell lines investigated (box, left to right) react to two drugs: the chemotherapy drug Taxol (top) and the kinase inhibitor Dasatinib (below gray line). The first line shows the reaction -- from blue to red: low to high sensitivity; the lines below show the abundance of different proteins in the cell lines: small number blue, high number red. Credit: A. Gholami/TUM

In what is the biggest study of its kind to date, researchers from Technische Universität München (TUM) have identified over 10,000 different proteins in cancer cells. "Nearly all anti-tumor drugs are targeted against cellular proteins," says Prof. Bernhard Küster, Head of the TUM Chair of Proteomics and Bioanalytics. "Identifying the proteome the protein portfolio of tumor cells increases our chances of finding new targets for drugs."

The scientists investigated 59 tumor cell lines from the US National Cancer Institute. The "NCI-60" cell lines represent the most common tumor diseases in nine tissues (e.g. brain, breast, bowels, skin, blood). Cancer researchers in all parts of the world use them in their experiments. TUM bioinformatics expert Dr. Amin Gholami elaborates: "Before now, there was little knowledge on the of the NCI-60 cell lines. But it is proteins that make the difference between a healthy cell and a tumor cell."

Proteins in tumor cells: a lot in common – and huge diversity

The scientists found over 10,000 different proteins in the NCI-60 cell lines. More than 5,000 of them are present in varying abundance in tumor cell lines of all types of tissue. "We can assume that this is the core proteome of cancer," comments Küster. However, the researchers also found some clearly distinguishable protein profiles between the tumor cells of different tissues – a clear indication that the tumor cells possess typical characteristics of healthy cells of the same tissue.

375 of the 10,000 or so proteins belong to the kinase group. These proteins are responsible for transmitting signals which cells use to control their , their division, or their communication with other cells in the tissue, for example. Tumor biologist Dr. Zhixiang Wu explains the wide range of different kinases in the NCI-60 cell line panel: "Unlike healthy cells, tumor cells are open to many signaling pathways in order to activate their division and ensure their survival."

Küster adds: "The kinases play a part in the continuous reproduction process of . The wide variety of shows how different these mechanisms are in human cancer diseases. This is an important discovery for personalized medicine."

Scientists use many other experimental cells in addition to the 59 tumor cell lines in the NCI-60 panel; in this case, lung cancer cells of cell line HCC827. Credit: K. Kramer/TUM

Effectiveness of drugs dependent on protein pattern

In another first, TUM researchers were able to prove that the protein pattern of the cells determines the effectiveness of cancer drugs. "We investigated how the cell lines react to 108 different cancer drugs and found that there are indeed proteins that indicate whether a cell will respond to certain therapeutic agents – or whether it will be resistant to the drug," explains Dr. Hannes Hahne, TUM expert in mass spectrometry techniques. As an example, he mentions the 14-3-3 zeta/delta protein, which is suspected of mediating resistance against cancer drugs.

The NCI-60 proteome database can be consulted by scientists. "We want to play our part to advance proteome research in the area of cancer diseases," concludes Küster. "Our next project will involve investigating the proteome of the 'Cancer Cell Line Encyclopedia', which pharmaceutical firms use to test new anti-cancer drugs."

Explore further: Protein involved in nerve-cell migration implicated in spread of brain cancer

More information: Global proteome analysis of the NCI-60 cell line panel; Amin Moghaddas Gholami, Hannes Hahne, Zhixiang Wu, Florian Johann Auer, Chen Meng, Mathias Wilhelm and Bernhard Küster, Cell Reports Volume 4, 2013, DOI: 10.1016/j.celrep.2013.07.018

Related Stories

Protein involved in nerve-cell migration implicated in spread of brain cancer

August 7, 2013
The invasion of brain-tumor cells into surrounding tissue requires the same protein molecule that neurons need to migrate into position as they differentiate and mature, according to new research from the University of Illinois ...

Researchers target 'cell sleep' to lower chances of cancer recurrence

August 1, 2013
An international research team led by University of Pittsburgh Cancer Institute (UPCI) scientists discovered that by preventing cancer cells from entering a state of cellular sleep, cancer drugs are more effective, and there ...

Scientists generate largest data set of cancer-related genetic variations

July 15, 2013
Scientists at the National Cancer Institute (NCI) have generated a data set of cancer-specific genetic variations and are making these data available to the research community, according to a study published in Cancer Research, ...

Researchers discover protein that may control the spread of cancer

February 26, 2013
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at ...

How tumor cells create their own pathways

July 10, 2012
Metastasis occurs when tumor cells "migrate" to other organs through the bloodstream. Scientists have now discovered the trick tumor cells use to invade tissue from the blood vessels: They produce signaling proteins to make ...

Recommended for you

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.